While CATNIP is formulated to specifically address postpartum physiology, all consenting adults are welcome to give it a try.

It is not intended for children, or pregnant and nursing adults. We recommend checking with your healthcare provider before use.

Safety has been a core priority from day one.

Before launch, the formulation went through an extensive pre-testing phase, during which multiple participants sampled the product over time. No adverse effects were reported during this testing period.

As with any dietary supplement, individual responses can vary. If you experience any unexpected reaction, discontinue use and consult a healthcare professional.

Take 1-2 capsules orally, 1-2 hours prior to pleasure. We recommend starting with the lowest dosage, and experimenting with different settings and times of day to identify your ideal conditions and dosage. Do not exceed 2 capsules in 24 hours.

CATNIP is an on-demand herbal supplement designed to support energy, sensation, presence, and connection during intimacy and beyond.

Participants have reported a range of experiences, including feeling more physically tuned in, more mentally present, and heightened enjoyment during intimate moments.

CATNIP is not intended to create desire where desire is absent, change consent, or override emotional, relational, physical, or environmental factors that may affect intimacy.

CATNIP is not intended to diagnose, treat, cure, or prevent any disease. Individual experiences may vary.

CATNIP was formulated by our co-founder, Michael Cunningham, PhD, who is also a co-founder of Gilgamesh Pharmaceuticals, a clinical-stage biotech developing treatments for depression and anxiety. His experience in both aphrodisiacs research and in drug development informed a careful, evidence-minded approach to ingredient selection, dosing, and stability.